Your browser doesn't support javascript.
loading
Salvage surgery for squamous cell carcinoma of the head and neck in the era of immunotherapy: Is it time to clarify our guidelines?
Saba, Nabil F; Mendenhall, William M; Hutcheson, Kate; Suárez, Carlos; Wolf, Greg; Ferlito, Alfio.
Affiliation
  • Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Mendenhall WM; Department of Radiation Oncology, University of Florida, Gainesville, Florida.
  • Hutcheson K; Section of Speech Pathology and Audiology, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Suárez C; Institute of Health Research of Asturias and Centro de Investigación Biomédica en Red Cáncer, Carlos III Institute of Health, Oviedo, Spain.
  • Wolf G; University Institute of Oncology of Asturias, University of Oviedo, Oviedo, Spain.
  • Ferlito A; Department of Otolaryngology-Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Michigan.
Cancer ; 124(21): 4163-4164, 2018 11 01.
Article in En | MEDLINE | ID: mdl-30289965

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salvage Therapy / Practice Guidelines as Topic / Squamous Cell Carcinoma of Head and Neck / Head and Neck Neoplasms / Immunotherapy / Medical Oncology Type of study: Guideline Limits: Humans Language: En Journal: Cancer Year: 2018 Type: Article Affiliation country: Georgia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salvage Therapy / Practice Guidelines as Topic / Squamous Cell Carcinoma of Head and Neck / Head and Neck Neoplasms / Immunotherapy / Medical Oncology Type of study: Guideline Limits: Humans Language: En Journal: Cancer Year: 2018 Type: Article Affiliation country: Georgia